News
- Jan (17)
- Feb (27)
- Mar (33)
- Apr (28)
- May (34)
- Jun (33)
- Jul (25)
- Aug (10)
- Sep (24)
- Oct (30)
- Nov (28)
- Dec (15)
- Jan (21)
- Feb (19)
- Mar (23)
- Apr (22)
- May (22)
- Jun (20)
- Jul (27)
- Aug (10)
- Sep (24)
- Oct (24)
- Nov (34)
- Dec (20)
- Jan (24)
- Feb (27)
- Mar (15)
- Apr (23)
- May (34)
- Jun (28)
- Jul (26)
- Aug (11)
- Sep (19)
- Oct (20)
- Nov (28)
- Dec (14)
- Jan (14)
- Feb (22)
- Mar (21)
- Apr (12)
- May (20)
- Jun (23)
- Jul (20)
- Aug (5)
- Sep (19)
- Oct (19)
- Nov (26)
- Dec (15)
- Jan (4)
- Feb (18)
- Mar (13)
- Apr (15)
- May (19)
- Jun (22)
- Jul (18)
- Aug (9)
- Sep (11)
- Oct (25)
- Nov (19)
- Dec (15)
- Jan (12)
- Feb (6)
- Mar (13)
- Apr (5)
- May (7)
- Jun (15)
- Jul (11)
- Aug (3)
- Sep (5)
- Oct (8)
- Nov (15)
- Dec (13)
Featured news
Latest news
IDIBAPS brings together experts to explore the role of NMDAR receptors in schizophrenia and encephalitis
“The sun doesn’t limit my life: I just have to put on sunscreen”
A new study shows targeted immunotherapy halves metastasis risk in high-risk early HER2+ breast cancer
The international DESTINY-Breast05 trial, published in The New England Journal of Medicine, demonstrates that the antibody-drug conjugate trastu1
A large population cohort provides a better understanding of mental health in Catalonia
A study led by Clínic Barcelona-IDIBAPS, in collaboration with the Healthcare Quality and Evaluation Agency of Catalonia (AQuAS), has for the first t1
The Clínic carries out a new pioneering therapy to reduce the risk of rejection in kidney transplants
On 26 September 2025, the Kidney Transplant Service at the Hospital Clínic Barcelona performed the first treatment with autologous tolerogenic dendri1
Four innovative Clínic-IDIBAPS projects funded by the Department of Health to advance medical technology and cell therapies
Professionals from Hospital Clínic-IDIBAPS are leading two projects in medical technology innovation and two in advanced drug and therapy development1
Innovations in transplants and advanced therapies: key contributions from the Clínic Barcelona Comprehensive Cancer Centre at ASH 2025
Hospital Clínic Barcelona and IDIBAPS, through the Clínic Barcelona Comprehensive Cancer Centre (4CB), had a prominent presence at the ASH 2025 Annua1
